Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
Anti-CD52 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD52 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD52 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD80 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD80 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD80 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Dickkopf-1 (Dkk-1) Antibody development. The ...
Jan 2019 $ 1250
Anti-Lymphotoxin - Pipeline Insight, 2019
By Delve Insight
"Anti-Lymphotoxin - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Lymphotoxin development. The report provides detailed coverag...
Jan 2019 $ 1250
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Mucin 1 (MUC1) Antibody development. The report p...
Jan 2019 $ 1250
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Apolipoprotein B (ApoB) Inhibitor development. Th...
Jan 2019 $ 1250
ATPase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"ATPase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "ATPase Inhibitor development. The report provides detailed coverag...
Jan 2019 $ 1250
Aurora Kinase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Aurora Kinase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Aurora Kinase Inhibitor development. The report provides de...
Jan 2019 $ 1250
Autophagy modulators - Pipeline Insight, 2019
By Delve Insight
"Autophagy modulators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Autophagy modulators development. The report provides detailed...
Jan 2019 $ 1250
Beta Secretase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Beta Secretase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Beta Secretase Inhibitor development. The report provides ...
Jan 2019 $ 1250
C1 Esterase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"C1 Esterase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "C1 Esterase Inhibitor development. The report provides detail...
Jan 2019 $ 1250
Cannabinoid Agonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Agonist development. The report provides detailed c...
Jan 2019 $ 1250
Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Receptor Type 1 (CB1) Agonist...
Jan 2019 $ 1250
Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Receptor Type 1 (CB1) Anta...
Jan 2019 $ 1250
Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Receptor Type 2 (CB2) Agonist...
Jan 2019 $ 1250
Carbonic Anhydrase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Carbonic Anhydrase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Carbonic Anhydrase Inhibitor development. The report p...
Jan 2019 $ 1250
Carnitine Palmitoyltransferase I (CPT 1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Carnitine Palmitoyltransferase I (CPT 1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Carnitine Palmitoyltransferase I...
Jan 2019 $ 1250
Cathepsin K/S Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cathepsin K/S Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cathepsin K/S Inhibitor development. The report provides de...
Jan 2019 $ 1250
CCR1 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR1 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR1 Inhibitor development. The report provides detailed coverage of...
Jan 2019 $ 1250
CCR3 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR3 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR3 Inhibitor development. The report provides detailed coverage of...
Jan 2019 $ 1250
CCR4 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR4 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR4 Inhibitor development. The report provides detailed coverage of...
Jan 2019 $ 1250
CCR5 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR5 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR5 Inhibitor development. The report provides detailed coverage of...
Jan 2019 $ 1250
CD 19 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 19 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 19 Inhibitor development. The report provides detailed coverage ...
Jan 2019 $ 1250
CD 33 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 33 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 33 Inhibitor development. The report provides detailed coverage ...
Jan 2019 $ 1250
CD 40 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 40 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 40 Inhibitor development. The report provides detailed coverage ...
Jan 2019 $ 1250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy